Literature DB >> 21525384

Analysis and modeling of the variable region of camelid single-domain antibodies.

Aroop Sircar1, Kayode A Sanni, Jiye Shi, Jeffrey J Gray.   

Abstract

Camelids have a special type of Ab, known as heavy chain Abs, which are devoid of classical Ab light chains. Relative to classical Abs, camelid heavy chain Abs (cAbs) have comparable immunogenicity, Ag recognition diversity and binding affinities, higher stability and solubility, and better manufacturability, making them promising candidates for alternate therapeutic scaffolds. Rational engineering of cAbs to improve therapeutic function requires knowledge of the differences of sequence and structural features between cAbs and classical Abs. In this study, amino acid sequences of 27 cAb variable regions (V(H)H) were aligned with the respective regions of 54 classical Abs to detect amino acid differences, enabling automatic identification of cAb V(H)H CDRs. CDR analysis revealed that the H1 often (and sometimes the H2) adopts diverse conformations not classifiable by established canonical rules. Also, although the cAb H3 is much longer than classical H3 loops, it often contains common structural motifs and sometimes a disulfide bond to the H1. Leveraging these observations, we created a Monte Carlo-based cAb V(H)H structural modeling tool, where the CDR H1 and H2 loops exhibited a median root-mean-square deviation to natives of 3.1 and 1.5 Å, respectively. The protocol generated 8-12, 14-16, and 16-24 residue H3 loops with a median root-mean-square deviation to natives of 5.7, 4.5, and 6.8 Å, respectively. The large deviation of the predicted loops underscores the challenge in modeling such long loops. cAb V(H)H homology models can provide structural insights into interaction mechanisms to enable development of novel Abs for therapeutic and biotechnological use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525384      PMCID: PMC3098910          DOI: 10.4049/jimmunol.1100116

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.

Authors:  R Stanfield; E Cabezas; A Satterthwait; E Stura; A Profy; I Wilson
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

2.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

3.  A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.

Authors:  K Decanniere; A Desmyter; M Lauwereys; M A Ghahroudi; S Muyldermans; L Wyns
Journal:  Structure       Date:  1999-04-15       Impact factor: 5.006

4.  Lateral recognition of a dye hapten by a llama VHH domain.

Authors:  S Spinelli; M Tegoni; L Frenken; C van Vliet; C Cambillau
Journal:  J Mol Biol       Date:  2001-08-03       Impact factor: 5.469

5.  Cyclic coordinate descent: A robotics algorithm for protein loop closure.

Authors:  Adrian A Canutescu; Roland L Dunbrack
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

6.  Structural repertoire of the human VH segments.

Authors:  C Chothia; A M Lesk; E Gherardi; I M Tomlinson; G Walter; J D Marks; M B Llewelyn; G Winter
Journal:  J Mol Biol       Date:  1992-10-05       Impact factor: 5.469

7.  A hierarchical approach to all-atom protein loop prediction.

Authors:  Matthew P Jacobson; David L Pincus; Chaya S Rapp; Tyler J F Day; Barry Honig; David E Shaw; Richard A Friesner
Journal:  Proteins       Date:  2004-05-01

8.  OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.

Authors:  R J Pantazes; C D Maranas
Journal:  Protein Eng Des Sel       Date:  2010-09-16       Impact factor: 1.650

9.  PIGS: automatic prediction of antibody structures.

Authors:  Paolo Marcatili; Alessandra Rosi; Anna Tramontano
Journal:  Bioinformatics       Date:  2008-07-19       Impact factor: 6.937

10.  Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies.

Authors:  S Muyldermans; M Lauwereys
Journal:  J Mol Recognit       Date:  1999 Mar-Apr       Impact factor: 2.137

View more
  28 in total

1.  IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.

Authors:  Johan Nilvebrant; D Cameron Dunlop; Aroop Sircar; Thierry Wurch; Emilia Falkowska; Janice M Reichert; Gustavo Helguera; Emily C Piccione; Simon Brack; Sven Berger
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Structure prediction, molecular simulations of RmlD from Mycobacterium tuberculosis, and interaction studies of Rhodanine derivatives for anti-tuberculosis activity.

Authors:  Harathi N; Sreenivasa Reddy P; Mounica Sura; Jayasimha Rayalu Daddam
Journal:  J Mol Model       Date:  2021-02-06       Impact factor: 1.810

3.  Synthetic single domain antibodies for the conformational trapping of membrane proteins.

Authors:  Iwan Zimmermann; Pascal Egloff; Cedric Aj Hutter; Fabian M Arnold; Peter Stohler; Nicolas Bocquet; Melanie N Hug; Sylwia Huber; Martin Siegrist; Lisa Hetemann; Jennifer Gera; Samira Gmür; Peter Spies; Daniel Gygax; Eric R Geertsma; Roger Jp Dawson; Markus A Seeger
Journal:  Elife       Date:  2018-05-24       Impact factor: 8.140

Review 4.  Structural and genetic diversity in antibody repertoires from diverse species.

Authors:  Miguel de los Rios; Michael F Criscitiello; Vaughn V Smider
Journal:  Curr Opin Struct Biol       Date:  2015-07-17       Impact factor: 6.809

5.  Humanization of Camelid Single-Domain Antibodies.

Authors:  Traian Sulea
Journal:  Methods Mol Biol       Date:  2022

6.  Generation of synthetic nanobodies against delicate proteins.

Authors:  Iwan Zimmermann; Pascal Egloff; Cedric A J Hutter; Benedikt T Kuhn; Philipp Bräuer; Simon Newstead; Roger J P Dawson; Eric R Geertsma; Markus A Seeger
Journal:  Nat Protoc       Date:  2020-04-08       Impact factor: 13.491

7.  Isolation and structural characterization of a Zn2+-bound single-domain antibody against NorC, a putative multidrug efflux transporter in bacteria.

Authors:  Sushant Kumar; Ithayaraja Mahendran; Arunabh Athreya; Rakesh Ranjan; Aravind Penmatsa
Journal:  J Biol Chem       Date:  2019-11-07       Impact factor: 5.157

8.  Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies.

Authors:  Yufei Xiang; Zhe Sang; Lirane Bitton; Jianquan Xu; Yang Liu; Dina Schneidman-Duhovny; Yi Shi
Journal:  Cell Syst       Date:  2021-02-15       Impact factor: 10.304

9.  Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.

Authors:  Clara T Schoeder; Samuel Schmitz; Jared Adolf-Bryfogle; Alexander M Sevy; Jessica A Finn; Marion F Sauer; Nina G Bozhanova; Benjamin K Mueller; Amandeep K Sangha; Jaume Bonet; Jonathan H Sheehan; Georg Kuenze; Brennica Marlow; Shannon T Smith; Hope Woods; Brian J Bender; Cristina E Martina; Diego Del Alamo; Pranav Kodali; Alican Gulsevin; William R Schief; Bruno E Correia; James E Crowe; Jens Meiler; Rocco Moretti
Journal:  Biochemistry       Date:  2021-03-11       Impact factor: 3.162

Review 10.  Macromolecular modeling and design in Rosetta: recent methods and frameworks.

Authors:  Julia Koehler Leman; Brian D Weitzner; Steven M Lewis; Jared Adolf-Bryfogle; Nawsad Alam; Rebecca F Alford; Melanie Aprahamian; David Baker; Kyle A Barlow; Patrick Barth; Benjamin Basanta; Brian J Bender; Kristin Blacklock; Jaume Bonet; Scott E Boyken; Phil Bradley; Chris Bystroff; Patrick Conway; Seth Cooper; Bruno E Correia; Brian Coventry; Rhiju Das; René M De Jong; Frank DiMaio; Lorna Dsilva; Roland Dunbrack; Alexander S Ford; Brandon Frenz; Darwin Y Fu; Caleb Geniesse; Lukasz Goldschmidt; Ragul Gowthaman; Jeffrey J Gray; Dominik Gront; Sharon Guffy; Scott Horowitz; Po-Ssu Huang; Thomas Huber; Tim M Jacobs; Jeliazko R Jeliazkov; David K Johnson; Kalli Kappel; John Karanicolas; Hamed Khakzad; Karen R Khar; Sagar D Khare; Firas Khatib; Alisa Khramushin; Indigo C King; Robert Kleffner; Brian Koepnick; Tanja Kortemme; Georg Kuenze; Brian Kuhlman; Daisuke Kuroda; Jason W Labonte; Jason K Lai; Gideon Lapidoth; Andrew Leaver-Fay; Steffen Lindert; Thomas Linsky; Nir London; Joseph H Lubin; Sergey Lyskov; Jack Maguire; Lars Malmström; Enrique Marcos; Orly Marcu; Nicholas A Marze; Jens Meiler; Rocco Moretti; Vikram Khipple Mulligan; Santrupti Nerli; Christoffer Norn; Shane Ó'Conchúir; Noah Ollikainen; Sergey Ovchinnikov; Michael S Pacella; Xingjie Pan; Hahnbeom Park; Ryan E Pavlovicz; Manasi Pethe; Brian G Pierce; Kala Bharath Pilla; Barak Raveh; P Douglas Renfrew; Shourya S Roy Burman; Aliza Rubenstein; Marion F Sauer; Andreas Scheck; William Schief; Ora Schueler-Furman; Yuval Sedan; Alexander M Sevy; Nikolaos G Sgourakis; Lei Shi; Justin B Siegel; Daniel-Adriano Silva; Shannon Smith; Yifan Song; Amelie Stein; Maria Szegedy; Frank D Teets; Summer B Thyme; Ray Yu-Ruei Wang; Andrew Watkins; Lior Zimmerman; Richard Bonneau
Journal:  Nat Methods       Date:  2020-06-01       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.